Yüklüyor......
HHLA2 is a novel prognostic predictor and potential therapeutic target in malignant glioma
Glioma is the most common and aggressive tumor type of the central nervous system and is associated with poor prognosis. To date, novel emerging immunotherapies have significantly improved outcomes for patients with various cancer types. Human endogenous retrovirus-H long terminal repeat-associating...
Kaydedildi:
| Yayımlandı: | Oncol Rep |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826309/ https://ncbi.nlm.nih.gov/pubmed/31578594 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2019.7343 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|